Healthcare
Omada Health(OMDA)
Live Price
Offline$17.14
-3.33% today
1Y Change
-1.20%
Window
Jun 25, 2025 β Jun 15, 2026
- Market Cap
- $900.00M
- Revenue Growth
- +53.2%
- EPS Growth
- +74.1%
- Dividend Yield
- 0.0%
Coverage: 244 bars Β· Jun 25, 2025 β Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Omada Health (OMDA) is a Healthcare stock with a market cap of $900.00M and listed on NASDAQ. The stock last traded around $17.14 and down 1.2% across the available one-year price window (Jun 25, 2025 β Jun 15, 2026). Baseline metrics include revenue growth of +53.2%, EPS growth of +74.1%, a dividend yield of 0.0%. What stands out right now is revenue +53.2%, EPS +74.1%, free cash flow +144.5% with operating margin -4.6% and ROIC -5.2%. Valuation is more restrained than many high-expectation growth names at price/sales 3.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines OMDA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+53.2% vs +7.6% peer median
Operating Margin
Below sector median
-4.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Jun 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +53.2% and EPS at +74.1%, with operating margin around -4.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Jun 4, 2026 | β | -1.5% | -2.6% | β |
2026 Mar 5, 2026 | +1427.6% | +3.3% | +3.1% | -7.5% |
2025 Nov 6, 2025 | +120.0% | -7.1% | -5.0% | -20.0% |
Benchmark Edge
OMDA vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OMDA
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OMDA Max Drawdown
-59.15%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for OMDA and SPY.
Company Overview
Omada Health
NASDAQ Global Market
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral healthβdelivered digitally between doctor visits.
- Leadership
- Sean Duffy
- IPO Date
- Jun 6, 2025
- Employees
- 849
- Street Address
- 500 Sansome Street
- Mailing
- San Francisco, CA, 94111
- Region
- San Francisco, CA, US
- Reporting Currency
- USD
- Investor Line
- 888 987 8337
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- β
- EV/EBITDA
- β
- Price/Sales
- 3.5
- Price/Book
- 3.9
Growth
- Revenue
- +53.2%
- EPS
- +74.1%
- Free Cash Flow
- +144.5%
Profitability
- Gross Margin
- 65.5%
- Operating Margin
- -4.6%
- Net Margin
- -4.9%
- ROE
- -7.1%
- ROIC
- -5.2%
Balance Sheet
- Debt/Equity
- β
- Current Ratio
- 3.60
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.